Innovating Life Sciences with Europe’s Pharmaceutical Strategy

7 min read

A flag of the European Community made of pills with a subtle overlay of European map with a bright and colorful background, digital art created with DALL-E

Unlock the transformative power of Europe’s Pharmaceutical Strategy in life sciences, fostering innovation and resilience in supply chains. Dive deep into its impact In the vast and intricate garden of life sciences, the Pharmaceutical Strategy for Europe, a pivotal document crafted by the European Commission, emerges as the nourishing rain, promising to breathe life into the landscape and fortify the Supply Chain against the unpredictable elements of the industry. As it was conceived amid the global pandemic, this document is not merely a strategy; it is a clarion call, a beacon of hope meticulously studied and understood, beckoning the attention of life science…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Flavio Aliberti Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.